Literature DB >> 24880663

The role of skin trauma in the distribution of morphea lesions: a cross-sectional survey of the Morphea in Adults and Children cohort IV.

Daniel Grabell1, Clifford Hsieh2, Rachel Andrew1, Kathryn Martires3, Andrew Kim4, Rebecca Vasquez1, Heidi Jacobe5.   

Abstract

BACKGROUND: Skin trauma may play a role in the development of morphea lesions. The association between trauma and the distribution of cutaneous lesions has never been examined to our knowledge.
OBJECTIVE: We sought to determine whether patients enrolled in the Morphea in Adults and Children (MAC) cohort exhibit skin lesions distributed in areas of prior (isotopic) or ongoing (isomorphic) trauma.
METHODS: This was a cross-sectional analysis of the MAC cohort.
RESULTS: Of 329 patients in the MAC cohort, 52 (16%) had trauma-associated lesions at the onset of disease. Patients with lesions in an isotopic distribution had greater clinical severity as measured by a clinical outcome measure (mean modified Rodnan Skin Score of 13.8 vs 5.3, P = .004, 95% confidence interval 3.08-13.92) and impact on life quality (mean Dermatology Life Quality Index score 8.4 vs 4.1, P = .009, 95% confidence interval 1.18-7.50) than those with an isomorphic distribution. Most frequent associated traumas were chronic friction (isomorphic) and surgery/isotopic. LIMITATIONS: Recall bias for patient-reported events is a limitation.
CONCLUSION: Of patients in the MAC cohort, 16% developed initial morphea lesions at sites of skin trauma. If these findings can be confirmed in additional series, they suggest that elective procedures and excessive skin trauma or friction might be avoided in these patients.
Copyright © 2014 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  Dermatology Life Quality Index; Morphea in Adults and Children cohort; localized scleroderma; modified Rodnan Skin Score; morphea; skin trauma

Mesh:

Year:  2014        PMID: 24880663      PMCID: PMC4135004          DOI: 10.1016/j.jaad.2014.04.009

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  13 in total

1.  Localization of sclerotic-type chronic graft-vs-host disease to sites of skin injury: potential insight into the mechanism of isomorphic and isotopic responses.

Authors:  Kathryn J Martires; Kristin Baird; Deborah E Citrin; Fran T Hakim; Steven Z Pavletic; Edward W Cowen
Journal:  Arch Dermatol       Date:  2011-09

Review 2.  Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.

Authors:  Swati Bhattacharyya; Jun Wei; John Varga
Journal:  Nat Rev Rheumatol       Date:  2011-10-25       Impact factor: 20.543

3.  Morphea with features of lichen sclerosus et atrophicus at the site of a herpes zoster scar: another case of an isotopic response.

Authors:  Andrea Forschner; Giesela Metzler; Gernot Rassner; Gerhard Fierlbeck
Journal:  Int J Dermatol       Date:  2005-06       Impact factor: 2.736

4.  The isomorphic response in morphealike chronic graft-vs-host disease.

Authors:  Asha R Patel; Steven Z Pavletic; Maria L Turner; Edward W Cowen
Journal:  Arch Dermatol       Date:  2008-09

Review 5.  Localized scleroderma.

Authors:  Ronald M Laxer; Francesco Zulian
Journal:  Curr Opin Rheumatol       Date:  2006-11       Impact factor: 5.006

6.  Generalized morphea-like lesions arising in mechanically-compressed areas by underclothes.

Authors:  Mutsuko Ehara; Takashi Oono; Osamu Yamasaki; Hironori Matsuura; Keiji Iwatsuki
Journal:  Eur J Dermatol       Date:  2006 May-Jun       Impact factor: 3.328

7.  Linear scleroderma after contusion and injection of mepivacaine hydrochloride.

Authors:  Takashi Ueda; Shiro Niiyama; Yasuyuki Amoh; Kensei Katsuoka
Journal:  Dermatol Online J       Date:  2010-05-15

Review 8.  Isotopic response.

Authors:  R Wolf; S Brenner; V Ruocco; F G Filioli
Journal:  Int J Dermatol       Date:  1995-05       Impact factor: 2.736

9.  Localized scleroderma severity index and global assessments: a pilot study of outcome instruments.

Authors:  Thaschawee Arkachaisri; Sally Pino
Journal:  J Rheumatol       Date:  2008-03-01       Impact factor: 4.666

10.  Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.

Authors:  P Clements; P Lachenbruch; J Siebold; B White; S Weiner; R Martin; A Weinstein; M Weisman; M Mayes; D Collier
Journal:  J Rheumatol       Date:  1995-07       Impact factor: 4.666

View more
  12 in total

Review 1.  Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.

Authors:  Caterina Ferreli; Giulia Gasparini; Aurora Parodi; Emanuele Cozzani; Franco Rongioletti; Laura Atzori
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

2.  Recurrent Plaque Morphea Successfully Treated with PDO Mono Threads and Topical Tacrolimus Ointment.

Authors:  Jagdish Sakhiya; Dhruv Sakhiya; Ashish Dedakiya; Madhav Purohit; Mihir Modi; Piyush Darji; Feral Daruwala; Nimish Dudhatra
Journal:  J Clin Aesthet Dermatol       Date:  2020-10-01

Review 3.  The Immunogenetics of Morphea and Lichen Sclerosus.

Authors:  Pooya Khan Mohammad Beigi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Histopathological changes in morphea and their clinical correlates: Results from the Morphea in Adults and Children Cohort V.

Authors:  Daniel Walker; Joseph S Susa; Sharif Currimbhoy; Heidi Jacobe
Journal:  J Am Acad Dermatol       Date:  2017-03-09       Impact factor: 11.527

Review 5.  Overview of Juvenile localized scleroderma and its management.

Authors:  Suzanne C Li; Rong-Jun Zheng
Journal:  World J Pediatr       Date:  2019-11-30       Impact factor: 2.764

6.  Deep morphea induced by interferon-β1b injection.

Authors:  Erika Yue Lee; Steven Jeremy Glassman
Journal:  JAAD Case Rep       Date:  2016-06-24

Review 7.  Morphea and Eosinophilic Fasciitis: An Update.

Authors:  Jorre S Mertens; Marieke M B Seyger; Rogier M Thurlings; Timothy R D J Radstake; Elke M G J de Jong
Journal:  Am J Clin Dermatol       Date:  2017-08       Impact factor: 7.403

Review 8.  Morphea: progress to date and the road ahead.

Authors:  Laila Abbas; Adrienne Joseph; Elaine Kunzler; Heidi T Jacobe
Journal:  Ann Transl Med       Date:  2021-03

9.  A novel patient-reported outcome for paediatric localized scleroderma: a qualitative assessment of content validity.

Authors:  C K Zigler; K Ardalan; S Lane; K L Schollaert; K S Torok
Journal:  Br J Dermatol       Date:  2019-10-23       Impact factor: 9.302

10.  Interferon beta-1a-induced morphea.

Authors:  Spencer A Bezalel; Bruce E Strober; Katalin Ferenczi
Journal:  JAAD Case Rep       Date:  2014-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.